logo
logo

This Women's Healthcare Company Raised $7.5 Million In A Public Offering And Says It's Targeting $25 To $30 Million Net Revenue By End Of 2023

Jul 03, 2023about 2 years ago

Amount Raised

$7.5 Million

PrincetonManufacturing

Description

PRINCETON, NJ / July 3, 2023 / Agile Therapeutics (NASDAQ:AGRX) announced the closing of its public offering in May. The women's healthcare company raised $7.5 million in gross proceeds after selling over 1.8 million shares of common stock at $3.95 per share. The offering came just weeks after Agile released its first quarter earnings showing increased demand for its low-dose birth control patch, Twirla®.

Company Information

Company

Agile Therapeutics

Location

500 College Road East Suite 310

Princeton, New Jersey, United States

About

Agile Therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® (levonorgestrel and ethinyl estradiol) transdermal system and our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Twirla® and our pipeline products are based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin.

Related People